Court Tosses $32M Verdict Against Vioxx

Related News

• Merck Will Pay $650M to End Discount Probes

  Feb 7, 08 3:59 PM CST
  Drug company Merck will dish out $650 million to resolve lawsuits and probes into marketing schemes, the Wall Street Journal reports. Central to the investigations is the company’s “nominal pricing,” which slashed some drug prices by 90% for hospitals but hid the discounts from Medicaid, even though federal law demands that drug companies offer the government program their lowest prices. More »

• Merck Recalls 1M Doses of Vaccine for Kids

  Dec 12, 07 7:14 PM CST
  Merck is recalling almost a million doses of a childhood vaccine after it found evidence of contamination at one of its factories, the AP reports. The pharmaceutical giant says no children have been harmed after taking Hib, which prevents meningitis and pneumonia, but the company is recalling its 10 lots and two lots of a combination vaccine for both Hib and hepatitis B. More »

• Big Pharma Faces Big Plunge

  Dec 6, 07 4:50 AM CST
  Patent protections on some of the pharmaceutical industry's best-selling drugs, like Lipitor, Plavix and Singulair, are due to expire in the next several years, and drug manufacturers have little in the pipeline to replace them. The drug companies will lose billions—as much as half their combined revenue—to generic competitors, triggering an unprecedented industry crisis, reports the Wall Street Journal. More »

• Merck to Settle Suits for $4.85B

  Nov 9, 07 5:19 AM CST
  Merck has agreed to shell out $4.85 billion to settle 27,000 Vioxx lawsuits brought by plaintiffs who argued that the pain medication damaged health and caused deaths. The agreement, one of the largest in history, must still be approved by 85% of the plaintiffs, but it's likely to go through, reports the New York Times. More »